mTOR: Alzheimer's disease prevention for APOE4 carriers

Ai-Ling Lin^{1

2}, D Allan Butterfield^{1

2}, Arlan Richardson^{1

2}

Affiliations

¹ Sanders-Brown Center on Aging, Department of Pharmacology and Nutritional Sciences, University of Kentucky, Lexington, Kentucky, USA.
² Sanders-Brown Center on Aging, Department of Biomedical Engineering, University of Kentucky, Lexington, Kentucky, USA.

Editorial

Ai-Ling Lin et al. Oncotarget. 2016.

. 2016 Jul 19;7(29):44873-44874.

doi: 10.18632/oncotarget.10349.

Ai-Ling Lin^{1

2}, D Allan Butterfield^{1

2}, Arlan Richardson^{1

2}

¹ Sanders-Brown Center on Aging, Department of Pharmacology and Nutritional Sciences, University of Kentucky, Lexington, Kentucky, USA.
² Sanders-Brown Center on Aging, Department of Biomedical Engineering, University of Kentucky, Lexington, Kentucky, USA.

No abstract available

Keywords: Alzheimer disease; mTOR; rapamycin.

Comment on

Rapamycin rescues vascular, metabolic and learning deficits in apolipoprotein E4 transgenic mice with pre-symptomatic Alzheimer's disease.
Lin AL, Jahrling JB, Zhang W, DeRosa N, Bakshi V, Romero P, Galvan V, Richardson A. Lin AL, et al. J Cereb Blood Flow Metab. 2017 Jan;37(1):217-226. doi: 10.1177/0271678X15621575. Epub 2015 Dec 31. J Cereb Blood Flow Metab. 2017. PMID: 26721390 Free PMC article.

1. Bell RD, et al. Nature. 2012;485:512–516. - PMC - PubMed
1. Lin AL, et al. J Cereb Blood Flow Metab. 2015 - PubMed
1. Heitman J, et al. Science. 1991;253:905–909. - PubMed
1. Richardson A, et al. Exp Gerontol. 2015;68:51–58. - PMC - PubMed
1. Blagosklonny MV. Oncotarget. 2015;6:19405–19412. doi: 10.18632/oncotarget.3740. - DOI - PMC - PubMed